Black Rock Inc. Design Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,274,191 shares of DSGN stock, worth $7.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,274,191

Previous 2,380,242 4.46%

Holding current value

$7.53 Million

Previous $6.31 Million 45.3%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$2.27 - $4.03 $240,735 - $427,385	-106,051 Reduced 4.46%	2,274,191 $9.16 Million
Q4 2023 Feb 13, 2024	SELL	$1.99 - $2.76 $47,109 - $65,337	-23,673 Reduced 0.98%	2,380,242 $6.31 Million
Q3 2023 Nov 13, 2023	SELL	$2.05 - $8.14 $1.21 Million - $4.8 Million	-590,136 Reduced 19.71%	2,403,915 $5.67 Million
Q2 2023 Aug 11, 2023	SELL	$4.99 - $7.64 $957,281 - $1.47 Million	-191,840 Reduced 6.02%	2,994,051 $18.9 Million
Q1 2023 May 12, 2023	SELL	$5.5 - $9.77 $1.77 Million - $3.15 Million	-322,133 Reduced 9.18%	3,185,891 $18.4 Million

Q4 2022 Feb 13, 2023	SELL	$7.86 - $17.2 $716,053 - $1.57 Million	-91,101 Reduced 2.53%	3,508,024 $36 Million
Q3 2022 Nov 14, 2022	BUY	$14.09 - $25.57 $833,973 - $1.51 Million	59,189 Added 1.67%	3,599,125 $60.2 Million
Q2 2022 Aug 12, 2022	BUY	$9.91 - $17.33 $3.86 Million - $6.74 Million	389,116 Added 12.35%	3,539,936 $49.6 Million
Q1 2022 May 12, 2022	BUY	$11.17 - $20.89 $10.4 Million - $19.5 Million	935,196 Added 42.21%	3,150,820 $50.9 Million
Q4 2021 Feb 10, 2022	BUY	$13.64 - $21.41 $12.3 Million - $19.3 Million	902,960 Added 68.79%	2,215,624 $47.4 Million
Q3 2021 Nov 09, 2021	SELL	$13.99 - $20.03 $1.27 Million - $1.82 Million	-90,678 Reduced 6.46%	1,312,664 $19.3 Million
Q2 2021 Aug 11, 2021	BUY	$19.02 - $29.78 $26.7 Million - $41.8 Million	1,403,342 New	1,403,342 $27.9 Million

Others Institutions Holding DSGN

# of Institutions

Shares Held

30.5M

Call Options Held

100

Put Options Held

100

View Full List

About Design Therapeutics, Inc.

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $185M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

More about DSGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account